Teva Pharmaceuticals Germany
Teva Pharmaceuticals Germany Technographics
Teva Pharmaceuticals Germany Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Teva Pharmaceuticals Germany and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 2900 Teva Pharmaceuticals Germany employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Teva Pharmaceuticals Germany has purchased the following applications: Microsoft 365 for Collaboration in 2021, DocuSign eSignature for Digital Signing in 2021, Usercentrics Consent Management Platform (CMP) for Governance, Risk and Compliance in 2020 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Teva Pharmaceuticals Germany is running and its propensity to invest more and deepen its relationship with Microsoft , DocuSign , Sitecore or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Teva Pharmaceuticals Germany revenues, which have grown to $1.14 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Teva Pharmaceuticals Germany intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Teva Pharmaceuticals Germany Tech Stack and Enterprise Applications
Teva Pharmaceuticals Germany Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2021 | 2021 |
In 2021, Teva Pharmaceuticals Germany implemented Microsoft 365 as its Collaboration platform. Public facing web assets indicate Microsoft 365 is in use on the company website, confirming a vendor footprint tied to Microsoft 365 for Collaboration.
The Microsoft 365 deployment aligns with standard Collaboration capabilities, including Exchange Online for corporate email, Microsoft Teams for meetings and chat, SharePoint Online for intranet and document management, and OneDrive for personal file storage. These modules support synchronous and asynchronous collaboration workflows, content sharing, and document lifecycle management across teams.
Operational coverage focuses on enterprise collaboration and content governance within Teva Pharmaceuticals Germany, supporting internal communications, team collaboration, and regulated document handling. Administration is organized around tenant level controls and Microsoft 365 native governance features, including identity management and policy driven information protection, to manage access and compliance in the Collaboration environment.
|
Teva Pharmaceuticals Germany Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, Teva Pharmaceuticals Germany implemented DocuSign eSignature as a Digital Signing solution on its public website. The deployment embeds DocuSign eSignature to enable web-based signature workflows for documents presented through the corporate site, leveraging eSignature capabilities, envelope management and embedded signing flows that are standard for Digital Signing platforms. The full application name DocuSign eSignature is used to centralize electronic signature handling for public-facing document transactions.
The implementation scope is website-level Digital Signing, supporting customer and partner facing acceptance and document submission processes that surface on the corporate site. Configuration appears focused on template management, signing ceremony configuration and admin console governance to control document lifecycles and access, with integration surface at the web front end to present signing experiences. Operational ownership is aligned to centralized application administration and the web content team, affecting customer engagement and contractual acceptance processes on the Teva.de site.
|
 |
|
|
Web Content Management | Content Management |
|
2019 | 2019 |
|
Teva Pharmaceuticals Germany TRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Usercentrics | Legacy | Usercentrics Consent Management Platform (CMP) | Governance, Risk and Compliance | TRM | n/a | 2020 | 2020 |
In 2020 Teva Pharmaceuticals Germany implemented Usercentrics Consent Management Platform (CMP) as a Governance, Risk and Compliance solution to manage consent on its public website. The deployment is focused on the corporate web estate, instrumenting consent capture and preference controls across consumer facing pages and localized German language properties. The Usercentrics Consent Management Platform (CMP) is configured to surface consent banners and a centralized preference center to collect and persist user choices.
Configuration emphasizes consent capture workflows, consent storage and audit logging, and consent lifecycle orchestration to support internal compliance processes. Implemented functional capabilities include cookie and tracker categorization, customizable consent dialogs, granular preference toggles and persistent consent records for auditability. Administrative controls enable policy configuration and consent versioning within the application to maintain policy provenance.
Operational ownership spans privacy, legal, marketing and web operations teams who administer banner content, policy labels and consent rule sets through Usercentrics Consent Management Platform (CMP). Governance changes focused on formalizing consent policy publication, delegated administrative roles and maintaining audit trails for consent events. The implementation is scoped to the website digital channel and aligns application level controls with German market privacy and consent requirements.
|
|
|
|
|
Treasury Management | TRM |
|
2012 | 2012 |
|
Teva Pharmaceuticals Germany IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2016 | 2016 |
|
Teva Pharmaceuticals Germany CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Web Application Firewalls (WAF) | CyberSecurity |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Teva Pharmaceuticals Germany
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Teva Pharmaceuticals Germany Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Teva Pharmaceuticals Germany IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Teva Pharmaceuticals Germany digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Teva Pharmaceuticals Germany Technographics
Teva Pharmaceuticals Germany is a Life Sciences organization based in Germany,
with around 2900 employees and annual revenues of $1.14 billion.
Teva Pharmaceuticals Germany operates a diverse technology stack with applications such as
Microsoft 365, DocuSign eSignature and Usercentrics Consent Management Platform (CMP),
covering areas like Collaboration, Digital Signing and Governance, Risk and Compliance.
Teva Pharmaceuticals Germany has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Microsoft, DocuSign and Usercentrics.
Teva Pharmaceuticals Germany recently adopted applications including
Microsoft 365 in 2021, DocuSign eSignature in 2021 and Imperva Sonar in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Teva Pharmaceuticals Germany’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Teva Pharmaceuticals Germany’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Teva Pharmaceuticals Germany technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.